2023•Biopharmaceutics & Drug DispositionOpen access

Selective inhibitory effects of suberosin on CYP1A2 in human liver microsomes

Sanjita Paudel, Hyoje Jo, Tae‐Ho Lee, Sangkyu Lee

Open full text 3 citations

Abstract

Abstract Suberosin is a natural phytoconstituent isolated from Citropsis articulata, especially employed for its anticoagulant properties. Although metabolic studies assessing suberosin have been conducted, it is possible interactions with drugs and food have not yet been investigated. In the present study, we analyzed the selective inhibitory effects of suberosin on cytochrome P450 (CYP) enzymes using a cocktail probe assay. Various concentrations of suberosin (0–50 μM) were incubated with isoform‐specific CYP probes in human liver microsomes (HLMs). We found that suberosin significantly inhibited CYP1A2‐catalyzed phenacetin O‐deethylation, exhibiting IC50 values of 9.39 ± 2.05 and 3.07 ± 0.45 μM with and without preincubation in the presence of β‐NADPH, respectively. Moreover, suberosin showed concentration‐dependent, but not time‐dependent, CYP1A2 inhibition in HLMs, indicating that suberosin acts as a substrate and reversible CYP1A2 inhibitor. Using a Lineweaver‐Burk plot, we found that suberosin competitively inhibited CYP1A2‐catalyzed phenacetin O‐deethylation. Furthermore, suberosin showed similar inhibitory effects on recombinant human CYP1A1 and 1A2. In conclusion, suberosin may elicit herb–drug interactions by selectively inhibiting CYP1A2 during the concurrent administration of drugs that act as CYP1A2 substrates.

Open-access reader

About this research paper

What this paper is about

Abstract Suberosin is a natural phytoconstituent isolated from Citropsis articulata, especially employed for its anticoagulant properties. Although metabolic studies assessing suberosin have been conducted, it is possible interactions with drugs and food have not yet been investigated. In the present study, we analyzed the selective inhibitory effects of suberosin on cytochrome P450 (CYP) enzymes using a cocktail probe assay. Various concentrations of suberosin (0–50 μM) were incubated with isoform‐specific CYP probes in human liver microsomes (HLMs). We found that suberosin significantly inhibited CYP1A2‐catalyzed phenacetin O‐deethylation, exhibiting IC50 values of 9.39 ± 2.05 and 3.07 ± 0.45 μM with and without preincubation in the presence of β‐NADPH, respectively. Moreover, suberosin showed concentration‐dependent, but not time‐dependent, CYP1A2 inhibition in HLMs, indicating that suberosin acts as a substrate and reversible CYP1A2 inhibitor. Using a Lineweaver‐Burk plot, we found that suberosin competitively inhibited CYP1A2‐catalyzed phenacetin O‐deethylation. Furthermore, suberosin showed similar inhibitory effects on recombinant human CYP1A1 and 1A2. In conclusion, suberosin may elicit herb–drug interactions by selectively inhibiting CYP1A2 during the concurrent administration of drugs that act as CYP1A2 substrates.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract Suberosin is a natural phytoconstituent isolated from Citropsis articulata, especially employed for its anticoagulant properties. Although metabolic studies assessing suberosin have been conducted, it is possible interactions with drugs and food have not yet been investigated. In the present study, we analyzed the selective inhibitory effects of suberosin on cytochrome P450 (CYP) enzymes using a cocktail probe assay. Various concentrations of suberosin (0–50 μM) were incubated with isoform‐specific CYP probes in human liver microsomes (HLMs). We found that suberosin significantly inhibited CYP1A2‐catalyzed phenacetin O‐deethylation, exhibiting IC50 values of 9.39 ± 2.05 and 3.07 ± 0.45 μM with and without preincubation in the presence of β‐NADPH, respectively. Moreover, suberosin showed concentration‐dependent, but not time‐dependent, CYP1A2 inhibition in HLMs, indicating that suberosin acts as a substrate and reversible CYP1A2 inhibitor. Using a Lineweaver‐Burk plot, we found that suberosin competitively inhibited CYP1A2‐catalyzed phenacetin O‐deethylation. Furthermore, suberosin showed similar inhibitory effects on recombinant human CYP1A1 and 1A2. In conclusion, suberosin may elicit herb–drug interactions by selectively inhibiting CYP1A2 during the concurrent administration of drugs that act as CYP1A2 substrates.

Key concepts: CYP1A2, Phenacetin, Microsome, Pharmacology, Chemistry, Cytochrome P450, Inhibitory postsynaptic potential, Drug interaction

Related papers

Back to paper searchBrowse research topicsOriginal source
Selective inhibitory effects of suberosin on CYP1A2 in human liver microsomes — Research Paper | ScholarLens